South African virus variant may resist antibody drugs; Pfizer/BioNTech vaccine seems to work vs UK variant

By Nancy Lapid

World
Thursday, 21 Jan 2021
4:33 AM MYT

FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

South African variant may resist current antibody treatments

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Report a mistake

What is the issue about?

Spelling and grammatical error

Factually incorrect

Story is irrelevant

Thank you for your report!

Next In World

Ukraine's Zaporizhzhia nuclear plant temporarily lost power overnight, IAEA says

Shooting at South African bar leaves 11 dead, including a young child, police say

US cites progress in meeting with Ukraine officials, sets further talks

Australian authorities urge thousands to flee New South Wales bushfires

Russian drones, missiles hit Ukraine power and transport sectors, Kyiv says

India caps airfares as IndiGo crisis leaves hundreds stranded for fifth day

FIFA faces backlash after awarding first Peace Prize to Donald Trump

UN agency says Chornobyl nuclear plant's protective shield damaged

Canada removes Syria from its list of foreign state supporters of terrorism

Spain to slaught 30,000 pigs amid swine fever control measures

Others Also Read

Load more

Home
For You
Bookmark
Audio
Search